Articles by tag: clinical-trial

LAG-3 agonist IMP761: first clinical success in autoimmune diseases

LAG-3 agonist IMP761 has shown clinical efficacy in suppressing T-cells for the first time. Learn about the revolution in treating autoimmune diseases without side effects. Read more.

Oncolytic Virotherapy of Pancreatic Cancer: Successes The Lancet

Analysis of the First Phase of Trials of an Oncolytic Virus Against Pancreatic Adenocarcinoma: The Lancet Data, Risks, Forecasts and What Was Not Written in the News. Read.

Gene therapy AB-1009 for Pompe disease: clinical trial

A clinical trial of gene therapy AB-1009 for late-onset Pompe disease (LOPD) has begun. Phase 1 analysis, mechanism of action, risks, and prognosis. Learn more.

Telitacicept in IgA Nephropathy: Phase 3 Results in NEJM

Interim Results of TELIGAN: Telitacicept Reduces Proteinuria by 58.9% vs 8.8% Placebo. Learn How the New Dual Inhibitor Is Changing the IgA Nephropathy Market.

Human Cell Rejuvenation Therapy Trials

Learn about the first clinical trial of ER-100 cell rejuvenation therapy from Life Biosciences. How epigenetic reprogramming can reverse aging. Read details.